Fair Value Calculator Fair Value Calculator
EN DE

MADHUSE (MADHUSE) Fair Value & Analysis

IN · Market cap ₹372M

M MADHUSE MADHUSE · BSE
Price₹17.39
Fair Value₹26.25
Upside+50.9%
Quality35/100
Watch MADHUSE for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹19.69 – ₹32.82

Fair value as of: Jul 5, 2026

From 12 valuation models · updated today

Share price −3.4% over the past month.

Price vs Fair Value (12 months)

₹27.09 ₹16.99 Fair Value ₹26.25 Jul 2025 Jul 2026

12‑month range ₹16.99 – ₹27.09 · fair‑value band ₹19.69 – ₹32.82 · the ₹17.39 price screens below the ₹26.25 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

MADHUSE (MADHUSE) currently trades at ₹17.39, while our model-based Fair Value estimate is ₹26.25 — implying the stock looks roughly 50.9% undervalued today. We read business quality at 35/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, MADHUSE generated revenue of ₹72.9M at a net margin of 38.6%. It earns a return on equity of 4.4%. The stock trades on a trailing P/E of 13.3. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹19.69 (bear case) to ₹32.82 (bull case); at ₹17.39, the current price sits below that range. The share trades about 42% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹72.9M
Revenue growth (YoY) +5,218%
Net margin 38.6%
Return on equity 4.4%
Free cash flow −₹120M FY2026
P/E ratio 13.3
More key figures
Operating margin -43.8%
EPS (TTM) ₹1.31

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

MADHUSE reported revenue of ₹10.9M in FY2026 versus ₹54.2K in FY2022, a compound +276.5%/yr. Reported net income was ₹28.1M in FY2026.

Revenue +276.5%/yr
FY22 ₹54.2K
FY23 ₹5.5K
FY24 ₹5.0K
FY25 ₹0
FY26 ₹10.9M
Net income
FY22 −₹947K
FY23 −₹1.4M
FY24 ₹1.2M
FY25 −₹8.3M
FY26 ₹28.1M

Is MADHUSE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "MADHUSE Fair Value". https://www.fairvalue-calculator.com/stock/MADHUSE

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is MADHUSE (MADHUSE) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹26.25 versus a price of ₹17.39 — about +51% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MADHUSE?
Our model-based fair value for MADHUSE is ₹26.25 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹17.39.
What is the quality score of MADHUSE?
MADHUSE has a Quality Score of 35/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of MADHUSE (MADHUSE)?
MADHUSE reported trailing-twelve-month revenue of about ₹72.9M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of MADHUSE?
The net profit margin of MADHUSE is about 38.6%, meaning it keeps roughly 38.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.